Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today

Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today

Positive results from a handful of patients treated have bolstered confidence in the company's cell-based approach to cancer treatment.